#Israel #Heart Failure #Petah-Tikva #Microtech #Medinol

Introduction

In a major leap forward in medical technology, Microtech, a subsidiary of Medinol Inc., has announced the launch of its pioneering implantable microsensor dedicated to monitoring heart failure. Recently, the first implantation was successfully conducted by Professor Erez Sharoni at Beilinson Medical Center in Petah-Tikva, Israel.

The Technology Behind the Microsensor

Microtech's innovative microsensor platform represents years of intensive research and development within the field of medical technology. This highly advanced device, which measures less than one millimeter and operates passively, is capable of transforming existing implants into smart devices. Through external ultrasound communication, it sequentially collects data and performs various functions seamlessly.

According to Professor Sharoni, who is the lead cardiothoracic surgeon at the facility, "This remarkable technology could transform the standard of care for patients suffering from heart failure, particularly those receiving Left Ventricular Assist Devices (LVAD) or heart transplants."

Clinical Impact and Data Utility

The data generated by these implanted sensors can be harnessed by specialists in heart failure to drive clinical decisions regarding patient treatment. Dr. Tuvia Ben-Gal, head of the Heart Failure Department at Rabin Medical Center, emphasized the urgent need for advanced monitoring, stating, "Heart failure is characterized by periods of stability followed by deteriorations requiring repeated hospitalizations. This groundbreaking technology will allow us to track patients’ parameters in real-time, intervening promptly to reduce morbidity and mortality."

Broader Healthcare Applications and Remote Monitoring

One of the most compelling features of Microtech's sensors is their integration into existing medical devices, allowing healthcare professionals to treat patients based on quantifiable physiological parameters rather than symptoms alone. Dr. Yoram Richter, CEO of Medinol, added, "With a compact home unit, patients equipped with Microtech technology can send immediate and highly accurate pressure data directly to their healthcare provider. Geographic distance or mobility issues will no longer be obstacles."

This unique capability holds significant promise for a wide array of clinical scenarios. Patients suffering from conditions such as glaucoma, hydrocephalus, and portal hypertension, among others, will benefit from enhanced access to healthcare while minimizing the need for in-clinic or hospital visits.

The Future of Medical Technology

Microtech’s microsensor is a testament to the ongoing transformations in the field of medicine. As healthcare shifts towards more personalized and technologically advanced approaches, the introduction of these smart sensors paves the way for a comprehensive and proactive care model. As stated by Medinol, the company is committed to revolutionizing disease diagnosis and treatment and re-evaluating current technologies to extend the physical and conceptual reach of physicians. Collaborating with healthcare professionals, Medinol is defining the future of medical devices today.

For further information, please visit Medinol's website or contact Jeff Roach, Chief Commercial Officer at [email protected]